Cargando…
Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report
BACKGROUND: Germline CDKN2A mutations are a well-known cause of familial atypical multiple mole melanoma (OMIM #155601) and melanoma-pancreatic cancer syndrome (OMIM #606719). Increased risk of head and neck squamous cell carcinoma (HNSCC), particularly oral squamous cell carcinoma (OSCC) in those w...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818223/ https://www.ncbi.nlm.nih.gov/pubmed/35123577 http://dx.doi.org/10.1186/s40463-022-00556-y |
_version_ | 1784645786822246400 |
---|---|
author | Jeong, Ah-Reum Forbes, Kimberly Orosco, Ryan K. Cohen, Ezra E. W. |
author_facet | Jeong, Ah-Reum Forbes, Kimberly Orosco, Ryan K. Cohen, Ezra E. W. |
author_sort | Jeong, Ah-Reum |
collection | PubMed |
description | BACKGROUND: Germline CDKN2A mutations are a well-known cause of familial atypical multiple mole melanoma (OMIM #155601) and melanoma-pancreatic cancer syndrome (OMIM #606719). Increased risk of head and neck squamous cell carcinoma (HNSCC), particularly oral squamous cell carcinoma (OSCC) in those with germline CDKN2A mutations, has been described. However, screening for HNSCC is not a routine practice in patients with CDKN2A germline mutations and these mutations are not a conventional test for HNSCC patients without obvious risk factors. CASE PRESENTATION: We describe a female with no smoking history who developed oral squamous cell carcinoma at age 39 and had a complex clinical course of recurrent multifocal squamous cell carcinoma (SCC) and carcinoma in situ of the oral cavity and oropharynx. Detailed family history demonstrated that her mother was diagnosed with OSCC and melanoma in her 40 s, and her maternal grandfather was diagnosed with metastatic melanoma in his 40 s. Genetic testing of the patient and her mother revealed CDKN2A c.301G>T mutation. She was referred to genetic counseling as well as to dermatology, gastroenterology, and neurology for cancer surveillance. She was treated with resections and has no evidence of disease 3 years after diagnosis. CONCLUSIONS: We report a family with a CDKN2A c.301 G>T mutation who also have significant history of OSCC, adding to the growing body of literature suggesting increased risk of HNSCC, particularly OSCC, in CDKN2A germline mutation carriers. It is important to consider CDKN2A mutation testing in familial HNSCC and young patients without obvious risk factors. Moreover, surveillance for HNSCC should be routine practice in those with a CDKN2A germline mutation. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-8818223 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88182232022-02-07 Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report Jeong, Ah-Reum Forbes, Kimberly Orosco, Ryan K. Cohen, Ezra E. W. J Otolaryngol Head Neck Surg Case Report BACKGROUND: Germline CDKN2A mutations are a well-known cause of familial atypical multiple mole melanoma (OMIM #155601) and melanoma-pancreatic cancer syndrome (OMIM #606719). Increased risk of head and neck squamous cell carcinoma (HNSCC), particularly oral squamous cell carcinoma (OSCC) in those with germline CDKN2A mutations, has been described. However, screening for HNSCC is not a routine practice in patients with CDKN2A germline mutations and these mutations are not a conventional test for HNSCC patients without obvious risk factors. CASE PRESENTATION: We describe a female with no smoking history who developed oral squamous cell carcinoma at age 39 and had a complex clinical course of recurrent multifocal squamous cell carcinoma (SCC) and carcinoma in situ of the oral cavity and oropharynx. Detailed family history demonstrated that her mother was diagnosed with OSCC and melanoma in her 40 s, and her maternal grandfather was diagnosed with metastatic melanoma in his 40 s. Genetic testing of the patient and her mother revealed CDKN2A c.301G>T mutation. She was referred to genetic counseling as well as to dermatology, gastroenterology, and neurology for cancer surveillance. She was treated with resections and has no evidence of disease 3 years after diagnosis. CONCLUSIONS: We report a family with a CDKN2A c.301 G>T mutation who also have significant history of OSCC, adding to the growing body of literature suggesting increased risk of HNSCC, particularly OSCC, in CDKN2A germline mutation carriers. It is important to consider CDKN2A mutation testing in familial HNSCC and young patients without obvious risk factors. Moreover, surveillance for HNSCC should be routine practice in those with a CDKN2A germline mutation. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2022-02-05 /pmc/articles/PMC8818223/ /pubmed/35123577 http://dx.doi.org/10.1186/s40463-022-00556-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Jeong, Ah-Reum Forbes, Kimberly Orosco, Ryan K. Cohen, Ezra E. W. Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report |
title | Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report |
title_full | Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report |
title_fullStr | Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report |
title_full_unstemmed | Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report |
title_short | Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report |
title_sort | hereditary oral squamous cell carcinoma associated with cdkn2a germline mutation: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818223/ https://www.ncbi.nlm.nih.gov/pubmed/35123577 http://dx.doi.org/10.1186/s40463-022-00556-y |
work_keys_str_mv | AT jeongahreum hereditaryoralsquamouscellcarcinomaassociatedwithcdkn2agermlinemutationacasereport AT forbeskimberly hereditaryoralsquamouscellcarcinomaassociatedwithcdkn2agermlinemutationacasereport AT oroscoryank hereditaryoralsquamouscellcarcinomaassociatedwithcdkn2agermlinemutationacasereport AT cohenezraew hereditaryoralsquamouscellcarcinomaassociatedwithcdkn2agermlinemutationacasereport |